{
  "trial_id": "NCT01117350",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Duration of Diabetes, Baseline HbA1c, Body Mass Index (BMI), Fasting Plasma Glucose (FPG), Previous Diabetes Treatment, Concomitant Medications, Renal Function (creatinine clearance), Hepatic Function (ALT, AST), History of Retinopathy, History of Cardiovascular Disease, Smoking Status, Alcohol Use, Baseline Weight, Baseline Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Body Mass Index (BMI) at week -2",
          "Body Mass Index (BMI)"
        ],
        [
          "Duration of Type 2 diabetes",
          "Duration of Diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c) at week -2",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "At least one diabetic late complication"
      ],
      "remaining_candidate_features": [
        "Fasting Plasma Glucose (FPG)",
        "Previous Diabetes Treatment",
        "Concomitant Medications",
        "Renal Function (creatinine clearance)",
        "Hepatic Function (ALT, AST)",
        "History of Retinopathy",
        "History of Cardiovascular Disease",
        "Smoking Status",
        "Alcohol Use",
        "Baseline Weight",
        "Baseline Blood Pressure"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Fasting Plasma Glucose, 7-point Plasma Glucose profiles, Hypoglycemia occurrence, Body weight, Adverse events, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index (BMI) at week -2",
          "Body Mass Index"
        ],
        [
          "Duration of Type 2 diabetes",
          "Duration of Diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c) at week -2",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "At least one diabetic late complication"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Fasting Plasma Glucose",
        "7-point Plasma Glucose profiles",
        "Hypoglycemia occurrence",
        "Body weight",
        "Adverse events"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Body Mass Index, HbA1c, Fasting Plasma Glucose, Duration of Diabetes, History of Hypertension, History of Cardiovascular Disease, History of Dyslipidemia, History of Retinopathy, History of Nephropathy, History of Neuropathy, Current Smoking Status, Region of Enrollment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index (BMI) at week -2",
          "Body Mass Index"
        ],
        [
          "Duration of Type 2 diabetes",
          "Duration of Diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c) at week -2",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "At least one diabetic late complication"
      ],
      "remaining_candidate_features": [
        "Fasting Plasma Glucose",
        "History of Hypertension",
        "History of Cardiovascular Disease",
        "History of Dyslipidemia",
        "History of Retinopathy",
        "History of Nephropathy",
        "History of Neuropathy",
        "Current Smoking Status",
        "Region of Enrollment"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, HbA1c at baseline, fasting plasma glucose (FPG) at baseline, systolic and diastolic blood pressure, lipid profile, smoking status, medical history (including presence of microvascular and macrovascular complications), concomitant medications, and quality of life scores.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index (BMI) at week -2",
          "body mass index (BMI)"
        ],
        [
          "Duration of Type 2 diabetes",
          "duration of diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c) at week -2",
          "HbA1c at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "At least one diabetic late complication"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "fasting plasma glucose (FPG) at baseline",
        "systolic and diastolic blood pressure",
        "lipid profile",
        "smoking status",
        "medical history (including presence of microvascular and macrovascular complications)",
        "concomitant medications",
        "quality of life scores"
      ]
    }
  }
}